Holota, S.; Yushyn, I.; Khyluk, D.; Vynnytska, R.; Lesyk, R.
N-(3-Cyano-4,5,6,7-tetrahydrobenzothiophen-2-yl)-2-[[5-[(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)amino]-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide. Molbank 2021, 2021, M1211.
https://doi.org/10.3390/M1211
AMA Style
Holota S, Yushyn I, Khyluk D, Vynnytska R, Lesyk R.
N-(3-Cyano-4,5,6,7-tetrahydrobenzothiophen-2-yl)-2-[[5-[(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)amino]-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide. Molbank. 2021; 2021(2):M1211.
https://doi.org/10.3390/M1211
Chicago/Turabian Style
Holota, Serhii, Ihor Yushyn, Dmytro Khyluk, Renata Vynnytska, and Roman Lesyk.
2021. "N-(3-Cyano-4,5,6,7-tetrahydrobenzothiophen-2-yl)-2-[[5-[(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)amino]-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide" Molbank 2021, no. 2: M1211.
https://doi.org/10.3390/M1211
APA Style
Holota, S., Yushyn, I., Khyluk, D., Vynnytska, R., & Lesyk, R.
(2021). N-(3-Cyano-4,5,6,7-tetrahydrobenzothiophen-2-yl)-2-[[5-[(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)amino]-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide. Molbank, 2021(2), M1211.
https://doi.org/10.3390/M1211